content

Community-BASED HCV Treaters

Part 1: HCV Treatment in People Who Inject Drugs (PWID)—The Critical Link to HCV Elimination

• From National Imperative to Local Action
  
• Simplified HCV Treatment and Guidelines
  
• Optimizing Community-Based HCV Care and Cure
  
  

Part 2: Option 1: Unpacking Substance Use Disorder & Its Impact on HCV Infection

• Anatomy of Addiction
• Harm-Reduction Principles, Practices, and Services: A Holistic Approach to Care
• Preventing HCV in High-Risk Populations
  ‍

Part 2: Option 2: Mastering HCV Management Skills

• Simplified HCV Guidelines: Pretreatment Assessment, Regimen Selection, and On-Treatment/Post-Treatment Monitoring
• Clinical Circumstances or Features That Warrant Consultation With and/or Referral to a Specialist
• Case-Based Application of Knowledge
• Tips, Tools, and Resources in Support of Patient-Specific Insurance Approval for DAA Therapy
  ‍

Community-Based Substance Use Disorder (SUD) Providers

• SUD Services Providers at the Forefront of HCV Elimination
• HCV Testing and Linkage to Care—The Critical First Steps
• The SUD Services Provider as an Advocate for the Treatment of HCV in PWID

Continuing Medical Education (CME) INFORMATION

Community-BASED HCV Treaters

Target Audience

This educational initiative is intended for primary care, community HCV treaters, hepatologists, gastroenterologists, infectious disease specialists, as well as non-clinical office staff.

learning objectives

Upon completion of this program, HCV Treaters will be better able to:

• Discuss national and local epidemiologic data on PWID with HCV
• Explain the biopsychosocial model of addiction and its implications on the HCV epidemic
• Describe the simplicity, effectiveness, and population benefits of treating HCV in PWID populations
• Implement AASLD/IDSA simplified HCV-treatment recommendations for the management of PWID with HCV
• Apply harm-reduction principles and practices to prevent post-cure HCV reinfection
• Address access barriers to HCV treatment and harm-reduction services

Community-Based Substance Use Disorder (SUD) Providers

Target Audience

This educational initiative is intended for addiction services/substance use disorder providers, medication-assisted treatment (MAT) providers, social workers, case managers, peer educators, peer advocates, as well as clinical (MDs, NPs, PAs, RNs, pharmacists) and nonclinical office staff.

learning objectives

Upon completion of this program, SUD providers will be better able to:

• Discuss national and local HCV epidemiology and infection risks among PWID populations
• Define HCV antibody positivity, HCV RNA positivity, and reflex testing
• Employ universal screening and updated HCV testing guidelines to all patients
• Provide education and counseling to PWID with HCV that supports referral to community-based HCV treaters

This CME/CE activity is supported by an educational grant from Gilead Sciences, Inc.

This CME/CE activity is supported by educational grants from Gilead Sciences, Inc., and AbbVie Inc.